AMAG Pharmaceuticals (AMAG): IDA Therapy Gets European Marketing Authorization
Posted on June 22, 2012 at 12:58 PM EDT
AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) said ferumoxytol, its treatment for iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD), has received marketing authorization from the European Commission. [More...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here